ADDEX THERAPEUTICS LTD SHARE OPTION PLAN Effective date: [DATE]Share Option Plan • December 17th, 2019 • Addex Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledDecember 17th, 2019 Company IndustryAddex Therapeutics Ltd is a Swiss corporation (“société anonyme” / “Aktiengesellschaft”) pursuant to Articles 620 et seq. of the Swiss Code of Obligations with unlimited duration and seat in Plan-les-Ouates, Canton of Geneva, Switzerland.
LICENSE AGREEMENT BETWEEN INDIVIOR UK LIMITED AND ADDEX PHARMA S.A. Certain confidential information contained in this document, marked by brackets and asterisks, has been omitted pursuant to Rule 406 of the Securities Act of 1933, as amended.License Agreement • December 17th, 2019 • Addex Therapeutics Ltd. • Pharmaceutical preparations • England and Wales
Contract Type FiledDecember 17th, 2019 Company Industry JurisdictionThis License Agreement (this “Agreement”) is entered into as of this 2nd day of January 2018, by and between Indivior UK Limited (Co. No. 7183451) with a registered address of 103-105 Bath Road, Slough, Berkshire, SL1 3UH (“Indivior”), and Addex Pharma S.A., a company organized under the laws of Switzerland (“Addex”).
AGREEMENTResearch and Development • December 17th, 2019 • Addex Therapeutics Ltd. • Pharmaceutical preparations • New Jersey
Contract Type FiledDecember 17th, 2019 Company Industry JurisdictionADDEX PHARMACEUTICALS Ltd. , a company organised and existing under the laws of and having its registered office at 12, chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland (hereinafter referred to as “ADDEX” or “a Party”)
ADDEX THERAPEUTICS LTD. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 17th, 2019 • Addex Therapeutics Ltd. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 17th, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 22 day of March 2018, by and among Addex Therapeutics Ltd., a corporation organized under the laws of Switzerland (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
WARRANT AGREEMENT made on February 14, 2018 amongWarrant Agreement • December 17th, 2019 • Addex Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledDecember 17th, 2019 Company IndustryAddex Therapeutics Ltd, c/o Addex Pharma SA, Chemin des Aulx 12, 1228 Plan-les-Ouates, Switzerland (hereinafter referred to as “Company”)